Vaccination against SARS-COV-2: side effects of the CHADOX1NCOV-19 vaccine (AstraZeneca)

• Autor(a) principal: Leones Sandoval, Héctor Alexander
• Data de Publicação: 2022
• Outros Autores: Guzmán Variña, Carmen Barba
• Tipo de documento: Artigo
• Idioma: spa
• Título da fonte: Sapienza (Curitiba)
• Texto Completo: https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/402
• topic: COVID-19; efeitos secundários; ChAdOx1 nCoV-19; fases clínicas; Vetor de adenovírus; COVID-19; side effects; ChAdOx1 nCoV-19; clinical trials; vector Adenovirus; COVID-19; efectos secundarios; ChAdOx1 nCoV-19; fases clínicas; vector Adenovirus

Covid-19 has impacted the world, altering diferente áreas of development sucha as economical and socials that caused considerable deaths to all social strata. Mass vaccination has been the object of a countermeasure for the pandemic, however, adverse reactions have occurred after vaccination that have concerned the general population. Therefore, it is intended to determine the relationship between side effects and predisposing factors after vaccination against SARS-CoV-2 using ChAdOx1 nCoV-19 (AstraZeneca). A bibliographic review has been carried out following the PRISMA guidelines of the studies found in PubMed and ScienceDirect, including a total of 16 studies. Through them we can asume that risk factors most related to the development of adverse effects to vaccination were women, young people, those under specific pharmacological treatment, with symptoms such as pain in the puncture area and headache standing out, however, the specific relationship between they, have not come to be clear yet due to lack of studies around the main topic.